Assess whether working capital should be a walk-away (f8d60a)

SITUATION Buy-side QoE lead owns this Legal, IP, and Regulatory review in a health-system acquiring a specialty practice. A Phase II that found groundwater impact is the triggering event; customer concentration and termination-for-convenience clauses is the evidence for whether working capital should be a walk-away.

DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using customer concentration and termination-for-convenience clauses after a Phase II that found groundwater impact.

HYPOTHESES TO TEST 1. Buy-side QoE lead can defend Proceed from customer concentration and termination-for-convenience clauses after a Phase II that found groundwater impact in a M&A Due Diligence challenge. 2. Buy-side QoE lead cannot defend Proceed from customer concentration and termination-for-convenience clauses; Reprice is what the extract actually supports after a Phase II that found groundwater impact. 3. A Phase II that found groundwater impact never reached the population in customer concentration and termination-for-convenience clauses — reopen intake, do not close working capital should be. 4. Two facts in customer concentration and termination-for-convenience clauses after a Phase II that found groundwater impact conflict for buy-side QoE lead; hold this Legal, IP, and Regulatory file.

ANALYSIS REQUIRED 1. Name the document buy-side QoE lead still needs before signing. 2. Test whether a Phase II that found groundwater impact is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in customer concentration and termination-for-convenience clauses. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read customer concentration and termination-for-convenience clauses against a Phase II that found groundwater impact and write the one fact that would move working capital should be for buy-side QoE lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (customer concentration and termination-for-convenience clauses after a Phase II that found groundwater impact). Lead with the M&A Due Diligence option customer concentration and termination-for-convenience clauses can support after a Phase II that found groundwater impact, then the two facts that force it, then the Monday action for buy-side QoE lead in a health-system acquiring a specialty practice.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on working capital should be, then the evidence in customer concentration and termination-for-convenience clauses, then the action for buy-side QoE lead - Hypothesis scorecard against customer concentration and termination-for-convenience clauses: supported / rejected / untestable - Named option among Proceed, Reprice, Walk and the fact that kills the others - Owner and next date for buy-side QoE lead in a health-system acquiring a specialty practice